HC Wainwright & Co. maintains uniQure at Buy, lowers price target to $65 from $80
HC Wainwright & Co. kept uniQure's rating at Buy but reduced its price target from $80 to $65, an 18.8% cut. The new target suggests a 212.8% upside from the Nov 17 close of $20.78, according to the firm.


